Bifeprunox
- Generic Name
- Bifeprunox
- Drug Type
- Small Molecule
- Chemical Formula
- C24H23N3O2
- CAS Number
- 350992-10-8
- Unique Ingredient Identifier
- AP69E83Z79
Overview
Bifeprunox is a novel atypical antipsychotic agent which, along with SLV313, aripiprazole and SSR-181507 combines minimal D2 receptor agonism with 5-HT receptor agonism.
Background
Bifeprunox is a novel atypical antipsychotic agent which, along with SLV313, aripiprazole and SSR-181507 combines minimal D2 receptor agonism with 5-HT receptor agonism.
Indication
Bifeprunox is being evaluated for the treatment of schizophrenia, psychosis, and Parkinson's disease.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath